Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating Expenses
General and administrative	$ 337,992	$ 288,829
Research and development	318,743	390,432
Professional fees	1,915,383	316,657
Total Operating Expenses	2,572,118	995,918
Total Operating Loss	(2,572,118)	(995,918)
Other Income	78,341	153
Net Loss	(2,493,777)	(995,765)
Net loss attributable to non-controlling interests	(14,625)	(1,132)
Net Loss attributable to CQENS Technologies, Inc	$ (2,479,152)	$ (994,633)
Basic loss per common share	$ (0.09)	$ (0.04)
Diluted loss per common share	$ (0.09)	$ (0.04)
Basic weighted average shares outstanding	27,060,695	26,184,670
Diluted weighted average shares outstanding	27,060,695	26,184,670
Comprehensive Loss:
Change in foreign currency translation adjustments	$ 42	$ (34)
Comprehensive Loss:	(2,493,735)	(995,799)
Comprehensive loss attributable to non-controlling interests	(14,604)	(1,149)
Comprehensive loss attributable to CQENS Technologies, Inc.	$ (2,479,131)	$ (994,650)